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Abstract
Background
Scrub typhus is an important endemic disease in tropical Asia caused by Orientia tsut-
sugamushi for which no effective broadly protective vaccine is available. The successful
evaluation of vaccine candidates requires well-characterized animal models and a better
understanding of the immune response against O. tsutsugamushi. While many animal spe-
cies have been used to study host immunity and vaccine responses in scrub typhus, only
limited data exists in non-human primate (NHP) models.
Methodology/Principle findings
In this study we evaluated a NHP scrub typhus disease model based on intradermal inocula-
tion of O. tsutsugamushi Karp strain in rhesus macaques (n = 7). After an intradermal inocu-
lation with 106 murine LD50 of O. tsutsugamushi at the anterior thigh (n = 4) or mock
inoculum (n = 3), a series of time course investigations involving hematological, biochemi-
cal, molecular and immunological assays were performed, until day 28, when tissues were
collected for pathology and immunohistochemistry. In all NHPs with O. tsutsugamushi inoc-
ulation, but not with mock inoculation, the development of a classic eschar with central
necrosis, regional lymphadenopathy, and elevation of body temperature was observed on
days 7–21 post inoculation (pi); bacteremia was detected by qPCR on days 6–18 pi; and
alteration of liver enzyme function and increase of white blood cells on day 14 pi. Immune
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assays demonstrated raised serum levels of soluble cell adhesion molecules, anti-O. tsutsu-
gamushi-specific antibody responses (IgM and IgG) and pathogen-specific cell-mediated
immune responses in inoculated macaques. The qPCR assays detected O. tsutsugamushi
in eschar, spleen, draining and non-draining lymph nodes, and immuno-double staining
demonstrated intracellular O. tsutsugamushi in antigen presenting cells of eschars and
lymph nodes.
Conclusions/Significance
These data show the potential of using rhesus macaques as a scrub typhus model, for eval-
uation of correlates of protection in both natural and vaccine induced immunity, and support
the evaluation of future vaccine candidates against scrub typhus.
Author summary
Scrub typhus is a febrile illness caused by bacteria that invade and live within cells of the
immune and blood vessel systems. Small earth-bound mites can bite humans and transmit
these bacteria into the skin. Scrub typhus is treatable with antibiotics, but currently there
is no scrub typhus vaccine available. Unfortunately if humans get scrub typhus, the
immune response is usually weak and short-lived, especially against different strains, and
affected individuals can get ill again within a year. This is a problem in areas where the
infection is very common and a vaccine could be an effective approach to protect suscepti-
ble humans against scrub typhus.
In this study, we characterized the immune response and disease features of scrub
typhus in rhesus macaques by inoculating the bacteria directly into the skin–similar to
the mite bite in nature–previously this had only been done in cynomolgus macaques
(Macaca fascicularis). We found that the scrub typhus symptoms and immune responses
of rhesus macaques resemble more closely the human responses than those of cynomolgus
macaques. Studying the immune response in rhesus macaques will help us to understand
how humans react against different bacterial proteins, to identify new markers of protec-
tion and to find the strongest vaccine candidates. This will then help us develop new and
better vaccines (and also diagnostics) against scrub typhus in the future.
Introduction
Scrub typhus is a common but under recognized acute febrile illness caused by Orientia tsutsu-
gamushi, a Gram-negative obligate intracellular bacterium. Mites (Acari: Trombiculidae),
serve as both the vector transmitting the bacteria during their larval stage (chigger) to verte-
brate hosts and the reservoir maintaining the bacteria during their life cycle [1]. The clinical
signs and symptoms of scrub typhus are similar to other infectious diseases, which complicates
clinical diagnosis. Despite available drugs (tetracyclines, chloramphenicol, azithromycin,
rifampicin), scrub typhus remains an underappreciated health care problem due to difficulties
in clinical and laboratory diagnosis, delayed treatment responses in northern Thailand and
southern India, and the lack of an effective vaccine [2].
Studies of scrub typhus pathogenesis and immunity, critical to vaccine development,
require suitable animal models to understand the interaction and temporal dynamics between
O. tsutsugamushi and host responses. Various animal models have been developed for scrub
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typhus, including mice, guinea pigs, and non-human primates (NHP) [3–7]. In mouse models,
both inbred and outbred mice developed clinical manifestations in various degrees; however,
the mouse models did not develop reproducible pathology resembling human scrub [8]. In
immunological studies, a CD8 T-cell mediated cytotoxic immune response was shown neces-
sary for clearance of O. tsutsugamushi and protection from lethal infection [9, 10]. Although
cell-mediated immunity (CMI) plays a central role in heterologous protection amongst the
different strains of O. tsutsugamushi in inbred mice it was short-lived and waned after few
months [11, 12]. Recently, apoptosis was proposed as a potential contributor to this phenome-
non in humans, but this alone does not explain all findings associated with the transience of
broad immune protection [11, 12]. A NHP model mimicking human disease will enable inves-
tigations into these mechanisms [4, 13].
Previous studies in NHPs; Chattopadhyay et al. evaluated a truncated recombinant 56-kDa
outer membrane protein of the Karp strain (Kp r56) as a vaccine candidate in cynomolgus
monkeys (Macaca fascicularis), which induced both cellular and humoral immune responses
that decreased local inflammation at the inoculation site, but did not confer protection to re-
infection [3]. Then, Walsh et al. characterized the eschar and regional lymph node using histo-
logical and immunohistochemistry staining and demonstrated the localization of O. tsutsuga-
mushi within the eschar and a regional lymph node. However, only two out of six monkeys
developed necrotic eschars with unequivocal black crusted ulcers at the injection site [14]. A
recent vaccine study using 47-kDa htrA candidate vaccines in cynomolgus monkeys demon-
strated induction of sterile immunity against high-dose homologous challenge of O. tsutsuga-
mushi. In addition, Paris et al. provided the first phenotypic correlates of immune protection
in scrub typhus and presented the time course dynamics of bacteremia and host immune re-
sponses [4, 5, 13, 14]. Clearly further detailed studies of natural and vaccine-induced immune
mechanisms in response to O. tsutsugamushi are required, with evaluation of other vaccine tar-
gets. Colony-reared cynomolgus monkeys are scanty compared to rhesus macaques (Macaca
mulatta) which are more widely used as infectious disease models, and are likely to have more
immunological data available. Even though cynomolgus macaques are considered suitable
NHP models for scrub typhus, the disease manifestations are mild and correlates of immune
protection appear delayed compared to humans. The aim of this study was to evaluate the role
of rhesus macaques for a standardized NHP disease model for scrub typhus, in view of dissect-
ing the dynamics of disease dissemination and early host-pathogen interactions in both natural
infection and the vaccination/challenge setting with further characterization of early innate
and adaptive immune responses. We anticipated that this study would provide improved data
on the factors/parameters associated with immune protection and provide an animal model
with sufficient parallels to humans for evaluating the safety, immunogenicity and efficacy for
future scrub typhus vaccine candidates.
Material and methods
Ethics statement
All animal research was performed strictly under approved Institutional Animal Care and
Use Committee (IACUC) protocol by the IACUC and Biosafety Review Committee at the
Armed Forces Research Institute of Medical Sciences (AFRIMS) Bangkok, Thailand, an AAA-
LAC International-accredited facility. The IACUC protocol number was PN12-01 (approved
31st Jan 2012). The animal research was conducted in compliance with Thai laws, the Animal
Welfare Act, and all applicable U.S. Department of Agriculture, Office of Laboratory Animal
Welfare and U.S. Department of Defense guidelines. All animal research adhered to the Guide
for the Care and Use of Laboratory Animals, NRC Publication (8th Edition) [15].
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Animals were housed individually in standard squeeze-type stainless steel cages with a min-
imum floor space of 4.4 square feet equipped with standard enrichments and exposed to ambi-
ent environmental conditions inside an Animal Biosafety Level 3 (ABSL-3) containment
laboratory. All NHPs were fed daily with commercially prepared old-world primate extruded
feed and supplemented with fresh fruit or vegetable four times per week. Fresh chlorinated
water (5–10 ppm) was provided ad libitum via automatic water valves. Cages were cleaned
daily and sanitized biweekly. Animals were trained for 2–3 weeks for pole-collar-chair restraint
prior to the commencement of the study in which no anesthesia was required. All other proce-
dures were performed under anesthesia using ketamine hydrochloride, and all efforts were
made to minimize stress, improve housing conditions, and to provide enrichment opportuni-
ties. Animals were euthanized by ketamine hydrochloride injection (5–20 mg/kg intramuscu-
larly) followed by barbiturate (86.7 mg sodium pentobarbital/kg) in accordance with the
Guidelines for the Euthanasia of Animals (2013 Edition of the American Veterinary Medical
Association).
Non-human primates
Laboratory-reared Indian-origin rhesus macaques (Macaca mulatta) from AFRIMS colony
were used in this study. The AFRIMS rhesus macaque colony was established in 1981. The
Indian-origin rhesus macaques were originally imported from primate centers in the USA
and have been reared at the AAALAC International-accredited AFRIMS facilities since 1999.
All monkeys utilized in this study were born and reared at AFRIMS. Six of 7 macaques had
participated in a prior malaria study (Plasmodium cynomolgi) and one was naïve. The seven
macaques (3 males and 4 females) were three years of age and weighed between 4.7–5.4 kg at
the start of the study. The animals had no prior exposure to O. tsutsugamushi with negative
antibody titers to O. tsutsugamushi and negative serology for Simian Immunodeficiency Virus
(SIV), Simian Retrovirus (SRV), Simian T-lymphotropic Virus (STLV-1) and Macacine
Herpesvirus 1 (B virus). The macaques were randomly allocated to either a ‘control or mock
infection’ (n = 3) or ‘O. tsutsugamushi infection’ (n = 4) group. One week prior to Inoculation
Day 0, macaques underwent a complete physical examination that included a blood draw
(total of 5.0 ml of whole blood) for complete blood count, blood chemistry analysis, O. tsutsu-
gamushi-specific quantitative real-time polymerase chain reaction (qPCR) assay, and immuno-
logical and serological tests to establish baseline values. All animals had good general health as
determined by the attending veterinary staff through complete physical examination and labo-
ratory examinations (completed blood count (CBC) and blood chemistry).
Orientia tsutsugamushi Karp inoculum
The human isolated strain (Karp, Papua New Guinea, 1943) of O. tsutsugamushi was propa-
gated in CD-1 Swiss mice at the Naval Medical Research Center, Silver Spring, Maryland, USA
[16]. Pre-aliquots of liver-spleen homogenates of O. tsutsugamushi (Karp strain) at 1x106
murine LD50 (MuLD50) were prepared and applied to the O. tsutsugamushi infected macaques
as previously described [4, 6]. The control animals received aliquots of liver-spleen homoge-
nates from healthy uninfected mice. A trained veterinarian performed all inoculations on
anesthetized macaques via intradermal injection (26G needle) on Inoculation Day 0.
Experimental design
All macaques were inoculated at the left anterior medial thigh, and were observed daily for
clinical signs including the development of skin lesion, regional and generalized lymphade-
nopathy, loss of appetite, and elevated body temperature. Rectal temperature was measured
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daily without anesthesia between 15:00 to 15:20 using pole and collar restraint. Local inocula-
tion sites were observed and scored following the Draize and Rise scoring protocols (S1
Table). Blood was drawn every other day for bacterial quantitation (qPCR) and at day 0, 14,
and 28 post inoculation (pi) for hematological, biochemical, and immunological bioassays.
Control monkeys were euthanized at day 28 pi while O. tsutsugamushi-infected monkeys were
euthanized at day 30 pi, and a panel of tissue specimens for histopathological examination and
cerebro-spinal fluid (CSF) were collected for O. tsutsugamushi qPCR quantification, and
immunohistochemical staining.
Bacterial quantitation
To determine and quantitate the bacterial load of O. tsutsugamushi post-inoculation, an O. tsu-
tsugamushi-specific 47kDa gene qPCR assay was performed on blood, CSF, tissues, and eschar
swab DNA preparations [6]. The rhesus-specific qPCR assay targeting the single copy macaque
oncostatin M (osm) gene was used to quantitate host cells in tissue samples as previously
described [6, 17]. Results are reported as the ratio of O. tsutsugamushi to host cell counts. PCR
reactions were performed on a CFX96 Real-Time System (BioRad, Foster City, CA, USA), “no
template” negative controls were run with each reaction and plasmid DNA served for standard
curves in serial dilutions from 106 to 3 copies/μl of 47 kDa protein and macaque osm genes.
The copy number was calculated from the cycle threshold using Bio-Rad software, and quanti-
tation of 47 kDa protein gene was expressed per 104 macaque cells. The area under the curve
was calculated using GraphPad Prism 7 software.
Hematological and biochemical analyses
Complete blood counts were performed to determine erythrocyte count, hemoglobin, hemato-
crit, platelet count, leukocyte count, leukocyte differential, mean red blood cell volume, mean
red blood cell hemoglobin, mean red blood cell hemoglobin concentration, and mean platelet
volume. Plasma collected from heparinized blood was assessed for the concentration of albu-
min, creatinine, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase,
cholesterol, total bilirubin, urea nitrogen, and creatinine kinase levels.
Serum levels of circulating soluble cell adhesion molecules (sCAMs)
Soluble E-selectin, L-selectin, ICAM-1, and VCAM-1 in macaque sera were assessed using E-
selectin (Abcam, Cambridge, UK), VCAM-1 (Uscn, Wuhan, China), and ICAM-1 (Abnova,
Taoyuan, Taiwan) ELISA kits following the manufacturer instructions. Serum samples were
diluted 1:10. All samples and standard dilutions were assayed in duplicate, the optical densities
measured using a microplate spectrophotometer (Multiskan Go; Thermo scientific, Waltham,
MA), and the concentrations of cell adhesion molecules were determined from a standard
curve.
Determination of anti-O. tsutsugamushi antibody responses (IFA and
ELISA)
Serum samples were assessed for O. tsutsugamushi-specific IgM and IgG antibody titers by
indirect immunofluorescence (IFA) and ELISA assays at D0, D14 and D28.
IFA
Antigen slides coated with O. tsutsugamushi Gilliam (Burma) and Litchfield (Australia) stains
were purchased from the Australian Rickettsial Reference Laboratory (Geelong, Australia).
Rhesus macaque (Macaca mulatta) scrub typhus model
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Serum samples were serially diluted two-fold from 1:100 to 1: 25,600 in 2% skimmed milk PBS
buffer and incubated onto the antigen slides for 30 min. After washing three times with PBS
buffer, slides were incubated with FITC-conjugated goat anti-monkey IgM or IgG (Brook-
wood Biomedical, Birmingham, AL) for 30 min, and mounted with fluorescence mounting
medium (Dako, Glostrup, Denmark) for fluorescence-based microscope endpoint titer
determination.
ELISA
O. tsutsugamushi strain Karp (Papua New Guinea) whole cell antigen was kindly provided by
the Naval Medical Research Center. One-half of a 96-well microtiter plate was coated with O.
tsutsugamushi antigen (100 μl/well), and the other half without antigen (100 μl PBS/well), and
stored at 4˚C (min. 48 hours). Following steps were performed at room temperature; plates
were washed with 0.1% Tween 20 (Sigma, St. Louis, MO, USA) in PBS, and blocked with
blocking buffer (5% Skim milk, 0.1% Tween 20 in PBS) for 1 hour. Diluted serum samples
(1:100 in blocking buffer), were added to all wells (100 μL/well) and incubated for 1 h. After
three wash cycles, incubation with horseradish peroxidase conjugated goat anti-monkey IgG
or IgM (Kirkegaard & Perry Laboratories, Gaithersburg, MD) with 100 μl/well at 1:2000 dilu-
tion followed for 1 hour. After three wash cycles, ABTS (2,20-azino-di-(3-ethylbenzthiazoline
sulfonic acid)) peroxidase substrate (Kirkegaard & Perry Laboratories, Gaithersburg, MD) was
added and incubated for 15 min. Optical densities were measured at 405 nm by Microplate
Spectrophotometer (Multiskan Go; Thermo scientific, Waltham, MA), and the net optical
density (OD) of each sample was obtained by subtracting the background OD (no antigen
reading value) from the O. tsutsugamushi-antigen OD. Positive serum samples (net OD >0.5)
were serially diluted (1:100, 1:400, 1:1600, 1:6400) to determine the endpoint titer. The titers
were expressed as the inverse of the highest dilution in which a net OD of 0.200 was ob-
tained. The mean net OD of three negative control sera was consistently less than an optical
density of 0.200.
Determination of antigen-specific IFN-γ production using ELISpot assay
Peripheral blood mononuclear cells (PBMC) were isolated from 4 ml heparinized blood sam-
ples as previous described [18]. ELISpot assays for gamma interferon (IFN-γ) were performed
as per the manufacturer’s instruction (Mabtech, 3421M-2A, Stockholm, Sweden) [18]. PBMC
were stimulated with 0.2 μg of 47kDa O. tsutsugamushi antigen (recombinant full-length
47kDa Karp strain was produced and purified by Biomatik, USA). Leucoagglutinin (PHA-L)
(Sigma, St. Louis, MO, USA) was used as a positive control at 0.5 μg per well, and there was no
antigen in negative control wells.
Histopathology
After 28 days pi, all infected macaques were euthanized and tissue specimens (normal skin,
inoculation site (eschar), draining lymph node, non-draining lymph node, lung, heart, spleen,
kidney, liver, bone marrow, mesenteric lymph node, ileum, meninges, brain, brain stem) were
collected. All tissues were fixed in 10% neutral buffered formalin solution (Sigma, St. Louis,
MO, USA) for at least 2 weeks and processed using an automated tissue processor (SLEE medi-
cal, Mainz, Germany). The tissues were then embedded into paraffin blocks and sectioned at
5 μm using a semi-automated rotary microtome (RM2245, Leica, Buffalo Grove, IL, USA). The
tissue sections were mounted onto poly L-lysine coated microscope slides, baked at 60 ˚C for
14–18 h, and stained with hematoxylin-eosin (H&E) or used for immunohistochemistry (IHC).
All histopathological sections were evaluated by a board certified veterinary pathologist.
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Immunohistochemistry
The formalin-fixed paraffin embedded tissues were processed as previously described as previ-
ously described [6, 19]. The anti-O. tsutsugamushi monoclonal antibody (clone 1C4B11) of the
56 kDa surface protein of O. tsutsugamushi was applied at dilution 1:2. Cell marker antibodies
used in this study contains CD1a clone NA1/34 at 1:100 (Dako, Glostrup, Denmark), poly-
clonal CD3 antibody at 1:100 (Dako, Glostrup, Denmark), CD14 clone NCL-L-CD14-223 at
1:75 (Leica, Newcastle, UK), CD31 clone JC70A at 1:2 (OxFab, Oxford, UK), CD68 clone KP-1
at 1:3 (OxFab, Oxford, UK), DCSIGN clone DC28 at 1:200, and HLADR clone CR3/43 at 1:2
(OxFab, Oxford, UK).
Images were acquired and examined using standard fluorescence microscopy (Nikon
Eclipse 80i using the NIS element software from Nikon Tokyo, Japan) and a confocal laser
scanning microscope (Zeiss LSM 700, using the AxioVision 40 v4.7.1.0 software from Carl
Zeiss Imaging Solutions Gmbh, Germany). Images were merged and minimally optimized as a
whole file following the requirements for scientific imagery [20], using Photoshop CS3
extended, version 10.0.
Statistical analyses
Statistical analyses were performed using GraphPad Prism Software v. 7 or STATA version 14
SE (StataCorp, Texas, USA). The results between the infected and non-infected groups were
compared using the non-parametric Mann-Whitney U- test. The data of surrogate markers
were expressed as median and inter-quartile range, unless otherwise stated. Significant differ-
ences between time points within a group were determined with the non-parametric Wilcoxon
t-test. Two-tailed P values less than 0.05 were considered significant.
Results
Clinical signs and symptoms
All O. tsutsugamushi inoculated macaques developed classical eschar lesions at the injection
site within 7 days. The eschars presented as small indurated, erythematous, vesiculo-papules
on day 5, with moderate perifocal erythema and edema, which grew in diameter with increas-
ing erythema, perifocal edema and demarked excoriation resulting in a dark central necrosis
with black crust and a raised indurated border on day 7. Eschars were completely painless,
with a round shape, indurated border and a necrotic zone of 6–10 mm in diameter. They
reached maximum size on day 10–12, and then decreased slowly in size until day 21–23 to
leave a hyperpigmented area, but no scar (Fig 1). Explicit regional lymphadenopathy (inguinal
draining lymph node) was observed in all O. tsutsugamushi inoculated macaques starting on
day 7 which developed into generalized lymphadenopathy and resolved before day 21 (Fig 2).
During the bacteremia phase (median qPCR-positivity from Day 6 to Day 16) the infected
macaques demonstrated a significantly higher core temperature (p = 0.0335), when the distri-
bution of the median rectal temperatures was compared. The duration of fever was 7 days (Fig
3), and interestingly, a brief paradoxical drop in rectal temperature was observed before the
onset bacteremia (as noted previously in cynomolgus macaques) [4].
Hematology and biochemistry
On day 14pi, hematological analyses demonstrated significantly elevated leukocyte (WBC)
counts in O. tsutsugamushi inoculated macaques compared to control macaques, and no
differences in erythrocyte (RBC) counts, hematocrit (Hct), hemoglobin (Hb), platelet, mean
red blood cell volume (MCV), mean red blood cell hemoglobin (MCH), and mean red blood
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cell hemoglobin concentration (MCHC) (S2 Table). Biochemical analyses demonstrated sig-
nificant changes of albumin and liver enzyme levels (aspartate transaminase, alanine transami-
nase, and alkaline phosphatase), but not creatinine, cholesterol, total bilirubin, urea nitrogen,
and creatinine kinase levels (S3 Table).
Bacteremia
To detect bacteremia in macaques, whole blood samples were collected every two days for
DNA extraction and 47 kDa O. tsutsugamushi qPCR assay. O. tsutsugamushi DNA was first
detected on day 6 for all inoculated macaques. The duration of bacteremia ranged from 6 to 18
days, and the bacterial loads ranged from 1 to 85 organisms / 10,000 macaque cells per time-
point (Table 1). Additional eschar swab specimens on days 12 and 14 demonstrated the pres-
ence of O. tsutsugamushi DNA in all samples. To reduce eschar crust damage only 2 swab
samples were performed. A large bacterial load was detected in animal BR1-02’s eschar, which
correlated with bacteremia results (Table 1).
Circulating soluble cell adhesion molecules
Evidence for endothelial and leukocyte activation was found by increased serum levels of solu-
ble cell adhesion molecules (sE-selectin, sICAM-1, and sVCAM-1) in O. tsutsugamushi-
Fig 1. Eschar development at the inoculation site of rhesus macaques (BR1-03) inoculated with O. tsutsugamushi Karp strain.
https://doi.org/10.1371/journal.pntd.0006305.g001
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Fig 2. Regional lymphadenopathy and eschar formation of inoculated rhesus macaques on day 10 pi. (A) control
macaque (BR1-04), (B) O. tsutsugamushi inoculated macaque (BR1-02).
https://doi.org/10.1371/journal.pntd.0006305.g002
Fig 3. Rectal temperature of O. tsutsugamushi inoculated rhesus macaques. The distribution of median (range) of rectal temperatures
compared between inoculated and uninfected macaques, was significantly raised in the infected macaque group during the time of
bacteremia from day 6 to day 16, (Mann Whitney U test, p = 0.033).
https://doi.org/10.1371/journal.pntd.0006305.g003
Rhesus macaque (Macaca mulatta) scrub typhus model
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infected macaques, when compared to mock-infected macaques. Soluble E-selectin and
sICAM-1, but not VCAM-1 serum levels were significantly elevated on day 14 pi compared to
controls (Fig 4).
Anti-O. tsutsugamushi antibody response
The IgM antibody titers increased rapidly to reach their highest dilution before D14 in both
IFA and ELISAs, while IgG levels increased more slowly and were highest at the D28 time-
point. The results from ELISA shown higher antibody titers compared to IFA results (Fig 5).
IgM and IgG antibody titers against O. tsutsugamushi increased in all infected macaques
(n = 4) and remained undetectable in the control group (n = 3).
Determination of antigen-specific IFN-γ production using ELISpot assay
The isolated PBMCs were subjected to the O. tsutsugamushi antigen-specific IFN-γ production
ELISpot assay. The median IFN-γ production increased in O. tsutsugamushi inoculated
macaques over time, and although the range was wide all O. tsutsugamushi inoculated
macaques showed induction of IFN-γ at D28 (Fig 6).
Histopathology
The histopathological evaluation of the submitted tissues noted no significant pathological
findings in 16 tissues of O. tsutsugamushi inoculated macaques when compared with control
macaques at D29, suggestive of complete recovery.
Table 1. Summary of clinical observations of O. tsutsugamushi inoculated rhesus macaques.
Subject ID Eschar Draining LN Bacteremia Area under the bacteremia curve
BR1-01 Day 6–16 Lymphadenopathy Day 6–16 10
BR1-02 Day 6–16 Lymphadenopathy Day 6–16 182
BR1-03 Day 6–18 Lymphadenopathy Day 6–18 16
BR1-05 Day 6–12 Lymphadenopathy Day 6–12 16
https://doi.org/10.1371/journal.pntd.0006305.t001
Fig 4. Time course of serum levels of soluble cell adhesion molecules in macaques, (A) sE-selectin, (B) sICAM, (C) sVCAM. Dot plots demonstrating the serum
levels of soluble cell adhesion molecules of infected (n = 4, solid circles) and controls (n = 3, hollow circles) macaques. Bars indicate median and interquartile ranges
(IQR). The asterisk indicates significant difference (P<0.05) when compared between O. tsutsugamushi-infected and control group results.
https://doi.org/10.1371/journal.pntd.0006305.g004
Rhesus macaque (Macaca mulatta) scrub typhus model
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Detection of O. tsutsugamushi in macaque tissues at D28
O. tsutsugamushi DNA was detected by qPCR in eschar and spleen samples of macaque BR1-
02, the draining lymph node of BR1-03, and in the non-draining lymph node in BR1-05. The
eschar sample contained the highest number of O. tsutsugamushi organisms compared to
other tissues.
Fig 5. Scrub typhus specific antibody titers in serum of O. tsutsugamushi inoculated macaques after inoculation, (A) IFA and (B) ELISA. Data are
shown as antibody titers for IFA and net OD translated into titers of IgM and IgG antibodies in infected macaques (n = 4). Bars indicate the geometric mean.
https://doi.org/10.1371/journal.pntd.0006305.g005
Fig 6. Ex vivo production of antigen-specific IFN-γ by PBMC of inoculated macaques. Data are shown as spot
forming cells per million peripheral blood mononuclear cells (SFC /106 PBMC) of individual macaques (Control;
n = 3, O. tsutsugamushi inoculation; n = 4), following 18 hours of stimulation with r47 protein. Bars indicated median.
https://doi.org/10.1371/journal.pntd.0006305.g006
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Immunohistochemistry staining of these tissue specimens with anti-O. tsutsugamushi
monoclonal antibody 1C4B11 demonstrated O. tsutsugamushi organisms in the dermis of the
eschar and in the parenchyma of all three tissues, and a large number of O. tsutsugamushi
organisms was observed in the eschar compared to spleen, draining lymph node, and non-
draining lymph node.
Phenotyping of O. tsutsugamushi infected cells
The highest number of intracellular O. tsutsugamushi organisms was observed in antigen-pre-
senting cells (APCs, HLADR+, Fig 7). In the eschar (BR1-02), O. tsutsugamushi was associated
with dendritic cells (HLADR+, DCSIGN+, CD1a+) and monocyte/macrophage (CD68+,
CD14+), but not T cells (CD3+) and endothelial cells (CD31+) (Fig 8), while in the spleen sec-
tion of the same macaque the only association of O. tsutsugamushi with a leucocyte phenotype
was within APCs (HLADR+) (Fig 7). For the draining and non-draining lymph node samples,
O. tsutsugamushi was found to associate with APCs (HLADR+) (Fig 7).
Discussion
Scrub typhus in rhesus macaques closely resembles human disease
This study characterized a rhesus macaque intradermal inoculation model of scrub typhus in
view of future vaccine development studies. Human scrub typhus is characterized by a febrile
illness, often with nonspecific symptoms, an early bacteremia period, during which an inocula-
tion eschar can develop, possible skin rash, a strong association with raised liver transaminases
and regional lymphadenopathy after ID inoculation of O. tsutsugamushi via mite bite, and sub-
sequent establishment of humoral and cellular immune responses [12, 21–24]. The clinico-
Fig 7. Localization of intracellular O. tsutsugamushi in antigen presenting cells (APCs) in macaque tissues, (A and E) Eschar: BR1-02, (B) Spleen: BR1-02, (C)
Draining lymph node (D-LN): BR1-03, (D) Non-draining lymph node (ND-LN): BR1-05 after 28 day pi. O. tsutsugamushi is labeled in green, APCs are
characterized by MHC class II receptor (HLADR) and shown in red. Panels A-D show O. tsutsugamushi organisms associated with APCs in eschar, spleen, draining and
non-draining lymph nodes. Panel E shows orthogonal views of confocal Z-stack images. DAPI nuclear counterstain in blue. Scale bars: 10 μm.
https://doi.org/10.1371/journal.pntd.0006305.g007
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pathophysiological responses observed in rhesus macaques after ID O. tsutsugamushi inocula-
tion demonstrated striking similarity to human disease, with development of fever during bac-
teremia, marked eschar formation, regional followed by generalized lymphadenopathy, similar
Fig 8. Co-localization of intracellular O. tsutsugamushi at macaque immune cells; (A) Dendritic cells; DC-SIGN labeling (B) Dendritic cells; CD1a labeling, (C)
Macrophages; CD68 labeling, (D) Monocytes/macrophages; CD14 labeling after 28 days pi. O. tsutsugamushi is labeled in green, and immune cells are shown in red.
DAPI nuclear counterstain in blue. Split green/red channel sub-images and the overlay in the larger panel. Scale bars: 10 μm.
https://doi.org/10.1371/journal.pntd.0006305.g008
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bacteremia onset and duration, altered liver function, increased WBC counts, and pathogen-
specific antibody (IgM and IgG) and cell-mediated immune responses. Additionally, time
course sCAM serum levels demonstrated endothelial and leucocyte activation in analogy to
published observations in humans [25].
Although pathophysiological features of human scrub typhus have been described in a
cynomolgus macaque (Macaca fascicularis) ID inoculation model, these data have not been
challenged by or compared to any alternative models i.e. rhesus macaques [26]. The rhesus
macaque response was characterized with an earlier onset of clinical disease, a more pro-
nounced eschar formation, stronger liver function damage and a bacteremia phase that corre-
sponded more closely with observations in humans (D6-16) (Table 2). Importantly, the
features and lesions serving as phenotypic correlates of immune protection described in our
recent scrub typhus vaccine-challenge study in cynomolgus macaques [3, 4, 13], were found to
be more pronounced and resembled more closely to human disease dynamics in the rhesus
macaque (Macaca mulatta) model: the distribution of fever was significantly raised during the
entire bacteremia phase; the eschar lesions were larger in size, more clearly delineated and
invariably demonstrated induration, erythema and central necrosis–features required for the
RISE score (S1 Table); bacteremia curves were consistent in onset (time-to-bacteremia); and
biochemistry/hematological markers (albumin reduction, increased liver transaminases and
leukocytosis) were more pronounced than previously in the cynomolgus macaque model.
The rhesus macaque is among the best-known species of Old World monkeys, and due to
its wide distribution, and large population, it is listed as “least concern” in the IUCN Red List
of Threatened Species. Although rhesus macaques have been well studied for a number of
important infectious diseases like tuberculosis, malaria, HIV/SIV-AIDS and recently for Zika,
it is important to remain cautious when interpreting data generated in rhesus macaque models
in the absence of known human disease mechanisms, as these may differ and prove imperfect
for research in certain conditions [27–29]. The extent of research involving rhesus macaques
and the broad availability of validated laboratory reagents, especially leucocyte immune-phe-
notyping reagents (i.e. mAbs, ELISAs, histopathology reagents, cytokines etc.) as well as pub-
lished procedures and protocols (i.e. antigen retrieval, antibody dilution optimizations and
conditions etc.) currently allow for more in-depth investigations in rhesus than cynomolgus
laboratory NHP models.
The available data on human scrub typhus was summarized for comparative purposes in
this study (Table 2), and is a non-exhaustive collation from non-standardized investigations
and serves for approximate guidance; these data were retrieved from old publications, where
scrub typhus pre-exposed and naïve volunteers were ID inoculated using O. tsutsugamushi sus-
pensions. Data on biochemistry, hematology and bacteremia included recent reports from
clinical patient series from Laos and Thailand.
Bacteremia, fever and symptoms onset post-inoculation
Our previous study with cynomolgus macaques used the same inoculum preparation (mouse
liver/spleen homogenate, dosed at 106 muLD50) as this study, but the bacteremia period in rhe-
sus macaques was shorter ranging from D6-D16 post-inoculation, than in the cynomolgus
macaques (ranged from D9-D21). The shorter duration and earlier onset of bacteremia is much
closer to human findings, where O. tsutsugamushi qPCR positivity is found as early as D2 up to
D12 of fever manifestation (not post-inoculation) [33]. Early studies involving human volun-
teers have demonstrated that a latency of approximately 3–4 days following the mite inoculation
before the onset of fever [23]. Hence, the human “rickettsemia phase” can be estimated at
approximately D5-6 to D15 post-inoculation, which is similar to our findings in rhesus model.
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A delay between onset of symptoms after pathogen exposure could be associated with pre-
existing partially protective immunity (disease endemic regions), variation of inoculum dos-
age, strain virulence and the inoculum route applied [3, 4, 12, 23]. Further characterization of
the effects of these factors on disease onset and manifestation is crucial, as they relate to the
major phenotypic correlates of immune protection in scrub typhus (fever, bacteremia, inocula-
tion lesion characteristics) and should be an object of future investigations [4]. The rhesus
Table 2. Comparison of clinical scrub typhus characteristics between cynomolgus and rhesus macaques.
Markers and clinical
signs
Cynomolgus macaques Rhesus macaques
(this study)
Human scrub typhus References
Fever Onset day 10 Onset day 7 Onset day 8 [4, 12, 30]
Peaked on day 14 Peaked on day 11 Peaked on day 11
Duration days 12–19 (7 days) Duration days 7–14 (7 days) Duration NA (due to treatment or
incomplete data)
Eschar Onset day 9 Onset day 6 Onset day 5–7 [4, 19, 30]
Peaked on day 15 Peaked on day 9 Peaked on day 9
Duration days 10 Duration days 12 Duration NA (due to treatment or
incomplete data)
Heterogeneous eschar manifestation,
moderate severity, not all macaques
developed eschars.
All animals developed full blown eschars
with necrotic centers, uniformly severe
eschar formation.
All inoculated naïve volunteers developed
full blown eschars with necrotic centers.
Bacteremia Onset day 9 (mean day 10) Onset day 6 (mean day 6) Onset day 8 (mean day 9) [4, 30, 31]
Peaked on day 16 Peaked on day 11 Peaked on days 8–10
Duration days 9–21 (11 days) Duration days 6–16 (10 days) Duration days NA (treated)
Lymphadenopathy Onset 3–4 days before fever onset (all
animals with LA)
Onset 1–2 days before fever onset (all
animals with LA)
NA. LA onset usually coinciding with
fever onset (approx. 60% of patients)
[4, 30]
Hematology and
Biochemistry
Significant differences in levels of platelets,
leukocyte and lymphocyte counts, protein,
albumin, globulin, albumin/globulin ratio,
alkaline phosphatase, urea nitrogen, and
creatinine kinase (no changes in LFTs)
Significant differences in levels of
leukocyte counts, albumin, alkaline
phosphatase, LFTs
Significant differences in levels of
platelets, leukocyte and lymphocyte
counts, protein, albumin, alkaline
phosphatase, LFTs, urea nitrogen,
creatinine kinase, C-reactive protein,
LDH
[4, 30, 32]
Cell adhesion
molecules
NA Elevated serum levels of soluble cell
adhesion molecules: sE-selectin,
sICAM-1, and sVCAM-1
Elevated sL-selectin levels correlated with
skin rash duration, eschar, elevated
WBCs, lymphocytes, and neutrophils
[25, 32]
(correlations NA) Elevated sE-selectin levels correlated with
illness duration, lymphadenopathy,
eschar, elevated WBCs and neutrophils
Cellular tropism Immunophenotyping of infected cells
included CD3, HLA-DR, CD68 and
neutrophil lysozyme
Immunophenotyping of infected cells
included CD3, CD4, CD8, HLA-DR,
CD68, CD14, DC-SIGN, CD1a, CD20,
CD15 and lysozyme
see ref [19] [4, 19]
Additional
considerations
Limitations in availability and compatibility
of reagents and antibodies.
Extensive characterization through
HIV/SIV studies, wide range of
reagents, detailed immunological data
available
Only limited time course data available on
relevant markers and clinical signs to
date.
Immune response dynamics comparable to
humans for IgG, IgM, CMI (crude
OT-WCA), ref [4]
Immune response dynamics
comparable to humans for IgG, IgM,
CMI (optimised OT-WCA,
recombinant p47kDa), ref [18]
Immune are incompletely characterized
highly limited antigen-specific, time
course or longitudinal data (IgG, IgM,
CMI (optimized WCA-OT), ref [18]
Most closely related model: scrub typhus (O.
tsutsugamushi)
Most closely related model: Rocky
mountain spotted fever (Rickettsia
rickettsii)
Note: NA not available; Days are post inoculation (pi), except where stated; LFT liver function tests (AST, ALT); OT-WCA O. tsutsugamushi whole cell antigen.
 One study in chigger-challenged healthy volunteers were exposed to chiggers for 9 days and as such could not be included for time course data [23].
https://doi.org/10.1371/journal.pntd.0006305.t002
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macaques developed significantly raised core temperatures during the bacteremia phase–a clini-
cally highly relevant feature used to estimate the bacteremia phase in humans. An animal model
that does not develop fever will always be limited due to its dependence on bacterial dissemina-
tion dynamics–a feature not regularly assessed in humans. The transformation of fever time
course data into area under the curve for comparisons between interventional/vaccine groups
are important, as these data correlated previously with the density of bacteremia [4, 33].
Cell adhesion molecules and cellular tropism of Orientia tsutsugamushi
The sCAM time course profiles with significant rise in sE-selectin and sICAM plasma levels
(unfortunately no rhesus sL-selectin assays were available at this time) provide additional sup-
port to corroborate the usefulness of this model for scrub typhus; a previous study in humans
demonstrated that elevated sE-selectin levels correlated significantly with the duration of
fever/illness before admission, the presence of eschar formation and lymphadenopathy, as well
as elevated WBCs and neutrophils [25]. The sample size of this study did not allow for correla-
tions to be made, but we anticipate these markers to be useful in future evaluations.
Immunophenotyping of infected host leucocytes revealed intracellular O. tsutsugamushi
infection only within host monocytes and dendritic cells in the skin (inoculation site), spleen,
draining and non-draining lymph node specimens, representing identical findings of the
cellular tropism for O. tsutsugamushi in humans [19]. O. tsutsugamushi infected exclusively
APCs—also in agreement with previous findings in human eschar biopsies—and no evidence
of endothelial infection was seen, although the co-localization imaging was done on D28 post-
mortem samples. The availability of validated antibodies for rhesus enabled characterization of
infected leucocyte subsets, including "inflammatory" monocytes expressing CD14/CD68, den-
dritic cell phenotypes with CD1a/DCSIGN positivity, but no intracellular infection of T-cells, or
endothelial cells was found. The new finding of numerous intact O. tsutsugamushi within Lang-
erhans cells, monocytes and dermal dendritic cells at the inoculation site following resolution of
infection, is suggestive of ongoing replication in the skin throughout the disease course, even
after healing of the eschar lesion (in untreated cases). The absence of endothelial infection and
scarring/sequelae dynamics again compare well with findings in human eschar biopsies [19].
At termination of the study (D28), the tissue specimens containing O. tsutsugamushi DNA,
as determined by qPCR-assay, included skin (inoculation site), spleen, draining and non-
draining lymph node specimens, suggesting that either these tissues had particularly high bac-
terial loads, or that they might be associated with bacterial persistence and potential relapse in
case of inadequate treatment [34]. All infected host cells in lymph nodes and spleen at D28
were APCs–these cellular subsets may represent a niche for this obligate intracellular bacte-
rium, and pathogen-host immunomodulation is likely to occur within them. No viability test-
ing was performed in this study, and no evidence for O. tsutsugamushi was found in lung and/
or liver as recently described in persistent infections in a C57BL/6 mouse model [35, 36]. Addi-
tional investigations into the phenotypes of infected cells in lymph node and other organs
throughout the disease course need to precisely address where orientiae invade, survive and
replicate, as this will contribute to our understanding of the immunopathophysiology and
facilitate discovery of immune correlates of protection in scrub typhus.
Immune responses
In humans, natural protective immunity against O. tsutsugamushi requires both humoral and
cell-mediated responses [21, 22, 37]. The antibody response dynamics in rhesus macaques
were identical to those observed previously in cynomolgus macaques, with increasing titers at
D14 and all animals reaching maximum titers at D28 for both IgG and IgM. Cell-mediated
Rhesus macaque (Macaca mulatta) scrub typhus model
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immune responses (CMI) were seen in all infected macaques at D28 of the study, however
only 2 macaques demonstrated strong responses (>500SFC/mio PBMC). In subsequent stud-
ies we have further optimized antigen and ELISpot assay conditions and observed consistent
CMI responses [18]. These results are comparable to responses seen in the control macaque
group in the previous cynomolgus study, where unvaccinated controls did not exhibit an
increase in the number of antigen-specific IFN-γ secreting cells until D21 after ID challenge
with O. tsutsugamushi [4].
The 47kDa htrA antigen ELISpot assay used in this study (based on peptide pools) was cho-
sen due to promising findings with a 47kDa htrA based vaccine candidate in a previous study
[4]. The cell-mediated immune response induced by the 47kDa htrA gene co-presented with
the pRhGM-CSF plasmid adjuvant was more rapid than the 47kDa antigen-specific cellular
response of the natural immune response. This may also be associated with the inoculum
route (intradermal) or inoculum dose, where a smaller dose would result in a delayed bacter-
emia and followed by a delayed cell-mediated response. The establishment of the strong cell-
mediated immune response in rhesus macaques (measured by a 47kDa htrA peptide-pool), is
further evidence for the suitability in vaccine evaluations, as IFN-γ and type-1 immune
responses have been associated with protection from O. tsutsugamushi infections in animal
models, and strong IFN-γ responses to O. tsutsugamushi infection have been associated with
acute scrub typhus in humans [3, 4, 12, 13, 21, 22, 38].
In summary, when comparing findings between both macaque models using the same inoc-
ulation preparation, strength and route, the rhesus macaques unequivocally produced more
reliable classic eschar formation with central necrotic crusts at the inoculation site than the
cynomolgus model. This study characterized scrub typhus disease features in rhesus macaques,
and provided data on cell adhesion molecule dynamics and the cellular tropism of O. tsutsuga-
mushi in rhesus macaques, which were similar to findings described in humans and of high
relevance in evaluating new animal models for vaccine development.
Importantly, the time course dynamics of eschar formation, temperature and bacteremia–
which all represent phenotypic correlates of immune protection in scrub typhus—occurred
earlier and more pronounced in the rhesus model. The aim was not to develop a lethal model,
but compare previous findings in cynomolgus macaques to those in rhesus macaques. Taking
into account all findings, the rhesus macaques disease characteristics following ID inoculation
resembled that of human patients with scrub typhus more closely and importantly more con-
sistently than cynomolgus macaques. In addition, the access to a broader panel of validated
immunologic assays/reagents for the rhesus macaques compared to cynomolgus and other
NHPs makes this laboratory animal a more useful model for scrub typhus to investigate immu-
nopathology, correlates of immune protection and vaccine candidate evaluations.
Further characterization and development of the rhesus macaque model for scrub typhus
should include the effect of increasing inoculum dosages, the variation of immunopathophysiolo-
gical responses and cross-protection to O. tsutsugamushi strains, treatment studies, and assess-
ment of elicited immune response dynamics of immunogenic antigens. These data will enable
more in-depth evaluation of correlates of protection for both natural and vaccine induced immu-
nity, to subsequently support the evaluation of future vaccine candidates against scrub typhus.
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